Dust from the Past: Asbestos Related Lung Disease, a Disease of the Elderly
摘要
To summarize the features and management of asbestos related lung disease while highlighting some potential challenges that may be faced by healthcare providers when managing this heterogenous group of disease in the elderly.
Recent FindingsImmunotherapy is effective in improving survival rates in patients with mesothelioma and asbestos related lung cancer; however, the elderly are currently under represented in clinical trials making it challenging for clinicians to possibly decide optimal treatment for this group of patients. Compensation claims for mesothelioma associated with occupational exposure is lower in older patients suggesting that awareness is low in this cohort.
SummaryThe geriatric population is a unique group of patients that present with unique challenges such as co-existing multi-morbidities, polypharmacy, frailty, and psychosocial/ social-economic issues. A more holistic approach including comprehensive frailty assessment is needed when managing this group of patients especially in asbestos associated malignant disorders.